PRPO vs. CLIR, MSAI, DAIO, AXDX, BNGO, ASTC, STAI, TLIS, TBIO, and SMIT
Should you be buying Precipio stock or one of its competitors? The main competitors of Precipio include ClearSign Technologies (CLIR), MultiSensor AI (MSAI), Data I/O (DAIO), Accelerate Diagnostics (AXDX), Bionano Genomics (BNGO), Astrotech (ASTC), Scantech AI Systems (STAI), Talis Biomedical (TLIS), Telesis Bio (TBIO), and Schmitt Industries (SMIT). These companies are all part of the "measuring and control equipment" industry.
Precipio vs.
Precipio (NASDAQ:PRPO) and ClearSign Technologies (NASDAQ:CLIR) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, valuation, community ranking, risk, earnings and media sentiment.
ClearSign Technologies has a consensus target price of $2.00, suggesting a potential upside of 250.88%. Given ClearSign Technologies' stronger consensus rating and higher probable upside, analysts clearly believe ClearSign Technologies is more favorable than Precipio.
Precipio has a beta of 1.04, meaning that its share price is 4% more volatile than the S&P 500. Comparatively, ClearSign Technologies has a beta of 1.18, meaning that its share price is 18% more volatile than the S&P 500.
In the previous week, Precipio had 1 more articles in the media than ClearSign Technologies. MarketBeat recorded 5 mentions for Precipio and 4 mentions for ClearSign Technologies. ClearSign Technologies' average media sentiment score of 0.93 beat Precipio's score of 0.72 indicating that ClearSign Technologies is being referred to more favorably in the news media.
ClearSign Technologies has lower revenue, but higher earnings than Precipio. ClearSign Technologies is trading at a lower price-to-earnings ratio than Precipio, indicating that it is currently the more affordable of the two stocks.
10.4% of Precipio shares are owned by institutional investors. Comparatively, 24.0% of ClearSign Technologies shares are owned by institutional investors. 13.3% of Precipio shares are owned by insiders. Comparatively, 16.9% of ClearSign Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Precipio has a net margin of -17.23% compared to ClearSign Technologies' net margin of -118.93%. Precipio's return on equity of -34.01% beat ClearSign Technologies' return on equity.
Precipio received 119 more outperform votes than ClearSign Technologies when rated by MarketBeat users. Likewise, 73.32% of users gave Precipio an outperform vote while only 41.02% of users gave ClearSign Technologies an outperform vote.
Summary
ClearSign Technologies beats Precipio on 10 of the 18 factors compared between the two stocks.
Get Precipio News Delivered to You Automatically
Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Precipio Competitors List
Related Companies and Tools
This page (NASDAQ:PRPO) was last updated on 4/26/2025 by MarketBeat.com Staff
Buy PRPO Stock Free PRPO Stock Alerts